Work

Phase II trial of paclitaxel, ifosfamide, and cisplatin (TIP) for previously untreated patients (pts) with intermediate- or poor-risk germ cell tumors (GCT).

Year: 2013

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2013.31.6_suppl.336

Authors: Darren Richard Feldman, James Hu, Tanya B. Dorff, Sujata Patil, Lindsay Joy Van Alstine, Lamia Momen, Maryann Carousso, Amanda Hughes, Jolie Snively-Solomon, Charlean Ketchens, Joel Sheinfeld, Manjit S. Bains, Dean F. Bajorin, George J. Bosl, Robert John Motzer, David I. Quinn

Institutions: Memorial Sloan Kettering Cancer Center, USC Norris Comprehensive Cancer Center

Language: English

Topic: Testicular diseases and treatments

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2590565764

Cites:

Cited by: 9

Related to: 10